Valmark Advisers Inc. Acquires 234 Shares of Johnson & Johnson (NYSE:JNJ)
Valmark Advisers Inc. Acquires 234 Shares of Johnson & Johnson (NYSE:JNJ)
Valmark Advisers Inc. grew its holdings in Johnson & Johnson (NYSE:JNJ – Get Rating) by 1.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,109 shares of the company's stock after purchasing an additional 234 shares during the period. Valmark Advisers Inc.'s holdings in Johnson & Johnson were worth $3,775,000 at the end of the most recent quarter.
据Valmark Advisers Inc.在提交给美国证券交易委员会的最新披露中称,该公司第三季度增持了强生(纽约证券交易所代码:JNJ-GET评级)的股份1.0%。在此期间,该公司又购买了234股,持有该公司23,109股股票。截至最近一个季度末,Valmark Advisers Inc.持有的强生股份价值3,775,000美元。
Other hedge funds and other institutional investors also recently modified their holdings of the company. Morton Brown Family Wealth LLC increased its holdings in Johnson & Johnson by 78.0% during the 2nd quarter. Morton Brown Family Wealth LLC now owns 178 shares of the company's stock worth $32,000 after acquiring an additional 78 shares during the period. Goodman Advisory Group LLC purchased a new position in Johnson & Johnson in the 2nd quarter worth approximately $39,000. First Bank & Trust grew its stake in Johnson & Johnson by 69.6% in the 2nd quarter. First Bank & Trust now owns 380 shares of the company's stock worth $67,000 after buying an additional 156 shares in the last quarter. Heritage Wealth Management LLC purchased a new position in Johnson & Johnson in the 2nd quarter worth approximately $84,000. Finally, Timber Creek Capital Management LLC grew its stake in Johnson & Johnson by 225.0% in the 3rd quarter. Timber Creek Capital Management LLC now owns 650 shares of the company's stock worth $106,000 after buying an additional 450 shares in the last quarter. Institutional investors own 67.94% of the company's stock.
其他对冲基金和其他机构投资者最近也调整了对该公司的持股。第二季度,Morton Brown Family Wealth LLC增持强生股份78.0%。Morton Brown Family Wealth LLC在此期间额外收购了78股,现在拥有178股该公司股票,价值3.2万美元。古德曼咨询集团在第二季度购买了强生的一个新头寸,价值约39,000美元。第一银行信托第二季度增持强生股份69.6%。First Bank&Trust现在拥有380股该公司股票,价值6.7万美元,在上个季度又购买了156股。遗产财富管理有限责任公司在第二季度购买了强生的一个新头寸,价值约84,000美元。最后,Timber Creek资本管理有限责任公司在第三季度增持强生股份225.0%。Wood Creek Capital Management LLC现在拥有650股该公司股票,价值10.6万美元,上个季度又购买了450股。机构投资者持有该公司67.94%的股份。
Wall Street Analysts Forecast Growth
华尔街分析师预测经济增长
JNJ has been the subject of a number of research reports. Barclays initiated coverage on shares of Johnson & Johnson in a research note on Monday, October 17th. They issued an "equal weight" rating and a $175.00 price target for the company. StockNews.com started coverage on Johnson & Johnson in a research report on Wednesday, October 12th. They set a "strong-buy" rating on the stock. SVB Leerink decreased their target price on Johnson & Johnson from $194.00 to $186.00 and set an "outperform" rating on the stock in a research report on Friday, January 20th. Atlantic Securities boosted their target price on Johnson & Johnson from $160.00 to $168.00 and gave the stock a "neutral" rating in a research report on Wednesday. Finally, Morgan Stanley boosted their target price on Johnson & Johnson from $176.00 to $180.00 and gave the stock an "equal weight" rating in a research report on Wednesday. Seven research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $182.75.
JNJ已经成为许多研究报告的主题。巴克莱在10月17日星期一的一份研究报告中首次对强生的股票进行了报道。他们对该公司进行了“同等权重”评级,并设定了175.00美元的目标价。10月12日,星期三,斯托克新闻网开始在一份研究报告中对强生进行报道。他们对该股设定了“强力买入”评级。SVB Leerink在1月20日(周五)的一份研究报告中将强生的目标价从194.00美元下调至186.00美元,并对该股设定了“跑赢大盘”的评级。大西洋证券周三在一份研究报告中将强生的目标价从160.00美元上调至168.00美元,并给予该股中性评级。最后,摩根士丹利在周三的一份研究报告中将强生的目标价从176.00美元上调至180.00美元,并给予该股“同等权重”的评级。7名研究分析师对该股的评级为持有,5名分析师给出了买入评级,一名分析师对该公司股票发出了强烈的买入评级。根据MarketBeat.com的数据,该公司的共识评级为“适度买入”,共识目标价为182.75美元。
Insiders Place Their Bets
内部人士下注
Johnson & Johnson Stock Down 0.4 %
强生股价下跌0.4%
Shares of NYSE:JNJ opened at $168.89 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.43 and a debt-to-equity ratio of 0.37. Johnson & Johnson has a 52-week low of $155.72 and a 52-week high of $186.69. The stock's fifty day simple moving average is $175.90 and its 200-day simple moving average is $171.04. The company has a market capitalization of $441.56 billion, a P/E ratio of 25.06, a P/E/G ratio of 3.00 and a beta of 0.56.
纽约证券交易所股票代码:JNJ上周五开盘报168.89美元。该公司的速动比率为1.18,流动比率为1.43,债务权益比为0.37。强生目前的52周低点为155.72美元,52周高点为186.69美元。该股的50日简单移动均线切入位为175.90美元,200日简单移动均线切入位为171.04美元。该公司市值为4,415.6亿美元,市盈率为25.06倍,市盈率为3.00倍,贝塔系数为0.56。
Johnson & Johnson (NYSE:JNJ – Get Rating) last announced its quarterly earnings results on Tuesday, January 24th. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $2.22 by $0.13. The company had revenue of $23.71 billion during the quarter, compared to analyst estimates of $23.90 billion. Johnson & Johnson had a return on equity of 35.94% and a net margin of 18.90%. The firm's revenue was down 4.4% on a year-over-year basis. During the same period in the prior year, the firm posted $2.13 earnings per share. As a group, equities research analysts forecast that Johnson & Johnson will post 10.55 earnings per share for the current fiscal year.
强生(纽约证券交易所代码:JNJ-GET Rating)最近一次公布季度收益是在1月24日,星期二。该公司公布本季度每股收益为2.35美元,比普遍预期的2.22美元高出0.13美元。该公司本季度营收为237.1亿美元,而分析师预期为239亿美元。强生的股本回报率为35.94%,净利润率为18.90%。该公司的收入同比下降了4.4%。去年同期,该公司公布的每股收益为2.13美元。作为一个整体,股票研究分析师预测,强生本财年每股收益将达到10.55欧元。
Johnson & Johnson Announces Dividend
强生宣布分红
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 7th. Shareholders of record on Tuesday, February 21st will be paid a dividend of $1.13 per share. The ex-dividend date of this dividend is Friday, February 17th. This represents a $4.52 annualized dividend and a yield of 2.68%. Johnson & Johnson's dividend payout ratio is presently 67.06%.
该公司最近还宣布了季度股息,将于3月7日(星期二)支付。2月21日(星期二)登记在册的股东将获得每股1.13美元的股息。本次股息除息日期为2月17日(星期五)。这意味着年化股息为4.52美元,收益率为2.68%。强生目前的派息率为67.06%。
Johnson & Johnson Company Profile
强生公司简介
(Get Rating)
(获取评级)
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets.
强生是一家控股公司,从事医疗保健领域产品的研发、制造和销售。它通过以下细分市场运作:消费者健康、制药和医疗设备。消费者健康部分包括用于婴儿护理、口腔护理、美容、非处方药、妇女健康和伤口护理市场的产品。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Johnson & Johnson (JNJ)
- EVs, Robotics Among Growth Drivers As Chipmaker STMicro Gaps Up
- Does Oil Services Firm NOV Have Enough Energy To Maintain Rally?
- Shopify Clears Cup-With-Handle Base: Can Momentum Continue?
- The Future Of E-Commerce: Analysis And New Data
- Chevron Delights Shareholders with $75 Billion in Share Buybacks
- 免费获取斯托克新闻网关于强生(JNJ)的研究报告
- 电动汽车和机器人成为增长动力,芯片制造商意法半导体出现缺口
- 石油服务公司NOV有足够的能量维持涨势吗?
- Shopify Clears杯柄基地:势头还能持续吗?
- 电子商务的未来:分析和新数据
- 雪佛龙以750亿美元的股票回购取悦股东
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.
接受《强生日报》的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯接收对强生及相关公司的最新新闻和分析师评级的每日摘要。